Eliot Charles

Eliot is a Venture Partner based in our London office, concentrating on early-stage investments and new company formation. He has held prominent roles in leading companies in the healthcare industry and has a successful track record of venture investing and creating new companies. Eliot started his career at Genentech in business development and later, ran the External R&D Affairs group at Amgen. While at other venture firms in the Bay area, he was involved in the formation of several new companies, including Affymax (AFFY) and Convergence, and joined another, Principia Biopharma (PRNB), as COO. Since moving to the UK, Eliot helped found MiroBio, a start-up out of Oxford University, and is actively working with other SR One portfolio companies as well as looking to create new ones.